Evidence map›Paper›PMID 36839070›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Biosynthesis of Silver Nanoparticles Produced Using

Kotryna Cekuolyte, Renata Gudiukaite, Vaidas Klimkevicius, Veronika Mazrimaite, Andrius Maneikis, Egle Lastauskiene

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Green synthesis of silver nanoparticles byFrontiers in microbiology · 2025
    Article
  8. HarnessingMolecules (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Heliyon · 2024
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kotryna CekuolyteInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekis Avenue 7, LT-10257 Vilnius, Lithuania.
Renata GudiukaiteInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekis Avenue 7, LT-10257 Vilnius, Lithuania.ORCID 0000-0001-7839-727X
Vaidas KlimkeviciusInstitute of Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.
Veronika MazrimaiteInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekis Avenue 7, LT-10257 Vilnius, Lithuania.
Andrius ManeikisFaculty of Electronics, Vilnius Gediminas Technical University, Sauletekis Avenue 11, LT-10223 Vilnius, Lithuania.
Egle LastauskieneInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekis Avenue 7, LT-10257 Vilnius, Lithuania.ORCID 0000-0001-6390-9033
Vilnius University · LTVilnius Gediminas Technical University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) are well known for their unique physical and chemical properties, which can be incorporated into a wide range of applications. The growing resistance of microorganisms to antimicrobial compounds promoted the use of AgNPs in antimicrobial therapy. AgNPs can be obtained using physical and chemical methods, but these technologies are highly unfriendly to nature and produce large amounts of side compounds (for example, sodium borohydride and

Indexed as

AgNPsGeobacillus bacterianitrate reductase

Identifiers

PMID36839070
PMCPMC9965977
OpenAlexW4320491027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.